merck glp-1 Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral Receptor Agonist GLP-1 Medications for Weight Loss
Description
D.IrwinN.DuffyN
That is the difference between Shotsy and MeAgain
Of note, the kidney function appears to be unaffected by the use of semaglutide
GLP-1 drugs may help with appetite and weight reduction, but they may also create clinically meaningful nutritional side effects, especially in patients with poor baseline diet quality, prolonged use, gastrointestinal side effects, or rapid weight loss
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease
